Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
about
Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo.Molecular definitions of autophagy and related processes.RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.Till Death Do Us Part: The Marriage of Autophagy and Apoptosis.Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
P2860
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
@en
type
label
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
@en
prefLabel
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
@en
P2860
P1433
P1476
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
@en
P2093
Dongxu Liu
Keqiang Huang
P2860
P2888
P304
P356
10.1007/S13277-015-4689-Z
P577
2016-01-21T00:00:00Z
P6179
1036828902